Tralokinumab is effective for the treatment of AD through 72 weeks across body regions, including the head/neck, trunk, and limbs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results